Vimarsana
Biggest News Aggregation in the World

Page 3 - Ellipses Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ellipses Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ellipses Pharma Today - Breaking & Trending Today

Ellipses Pharma Announces Intent to Accelerate Clinical Programme Following 'Encouraging' Data on Next Generation Selective RET Inhibitor | Illinois - Vimarsana News

Ellipses Pharma Announces Intent to Accelerate Clinical Programme Following 'Encouraging' Data on Next Generation Selective RET Inhibitor | Illinois

CHICAGO--(BUSINESS WIRE)--Jun 5, 2023--

Source: wsiltv.com
Pemigatinib Demonstrates Activity in Previously Treated Solid Tumors Harboring Activating FGFR Alterations - Vimarsana News

Pemigatinib Demonstrates Activity in Previously Treated Solid Tumors Harboring Activating FGFR Alterations

Pemigatinib generated efficacy and tolerability in previously treated patients with advanced/metastatic or unresectable solid tumors harboring activating FGFR mutations or fusions/rearrangements, including cholangiocarcinoma, central nervous system tumors, gynecologic tumors, and pancreatic cancer.

BI 907828 Demonstrates Early Efficacy, Safety in MDM2-amplified Dedifferentiated Liposarcoma - Vimarsana News

BI 907828 Demonstrates Early Efficacy, Safety in MDM2-amplified Dedifferentiated Liposarcoma

The oral MDM2/p53 antagonist BI 907828 elicited preliminary antitumor activity and had a manageable safety profile in patients with MDM2-amplified dedifferentiated liposarcoma.

Ellipses Pharma: Expansion of Scientific Affairs Group - Vimarsana News

Ellipses Pharma: Expansion of Scientific Affairs Group

More than 200 oncologists worldwide now involved in assessment and selection of potential treatments Ellipses Pharma ("Ellipses"), a global drug development company focused on accelerating the development

Ellipses Pharma has "quite a number" of promising cancer treatments in the pipeline - Vimarsana News

Ellipses Pharma has "quite a number" of promising cancer treatments in the pipeline

Ellipses Pharma founder and chairman Professor Sir Christopher Evans speaks to Proactive about his work at the cancer-focused international drug development...